Overview

Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)

Status:
Terminated

Trial end date:
2020-03-26

Target enrollment:

Participant gender:

Summary

This clinical study compares the efficacy, safety, and tolerability of therapy with ponesimod vs placebo in subjects with active RMS who are treated with DMF (Tecfidera®).

Phase:

Phase 3

Details

Lead Sponsor:

Actelion

Treatments:

Dimethyl Fumarate
Ponesimod